Craig A. Smith
35Patents
18h-index
22Co-inventors
81Inventor score
Filing activity: May 10, 1990 → Jan 3, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5605690A | Methods of lowering active TNF-.alpha. levels in mammals using tumor necrosis factor receptor | Emerging Cross-Sectional Technologies | 297 | Expired |
| US5840059A | Therapeutic and diagnostic agent delivery | Human Necessities | 248 | Expired |
| US5997525A | Therapeutic and diagnostic agent delivery | Human Necessities | 139 | Expired |
| US5395760A | DNA encoding tumor necrosis factor-.alpha. and -.beta. receptors | Human Necessities | 134 | Expired |
| US5480981A | CD30 ligand | Chemistry; Metallurgy | 134 | Expired |
| US6224584A | Therapeutic and diagnostic agent delivery | Performing Operations; Transporting | 114 | Expired |
| US6355779B1 | Cytokine designated 4-1BB ligand antibodies and human receptor that binds thereto | Chemistry; Metallurgy | 104 | Expired |
| US6541610B1 | Fusion proteins comprising tumor necrosis factor receptor | Emerging Cross-Sectional Technologies | 70 | Expired |
| US5674704A | Cytokine designated 4-IBB ligand | Chemistry; Metallurgy | 65 | Expired |
| USRE36755E | DNA encoding tumor necrosis factor-.alpha. and -.beta. receptors | General | 54 | Expired |
| US5712155A | DNA encoding tumor necrosis factor-.alpha. and -.beta. receptors | Physics | 39 | Expired |
| US6572852B2 | Method for suppressing inflammatory responses by administering TNFR | Physics | 31 | Expired |
| US5464938A | Isolated viral protein TNF antagonists | Chemistry; Metallurgy | 31 | Expired |
| US6201105A | Tumor necrosis factor receptor polypeptides recombinant P75 (Type II) | Physics | 30 | Expired |
| US7138500B1 | Antibodies to human 4-1BB | Chemistry; Metallurgy | 23 | Expired |
| US8377448B2 | CD47 related compositions and methods for treating immunological diseases and disorders | Chemistry; Metallurgy | 23 | Active |
| US5945397A | Purified p75 (type II) tumor necrosis factor receptor polypeptides | Human Necessities | 23 | Expired |
| US5871740A | Methods of using poxvirus p35 as a chemokine inhibitor and compositions therefore | Emerging Cross-Sectional Technologies | 22 | Expired |
| US5422248A | DNA sequences encoding granulocyte-colony stimulating factor receptors | Chemistry; Metallurgy | 16 | Expired |
| US5589456A | Granulocyte-colony stimulating factor receptors | Chemistry; Metallurgy | 14 | Expired |
| US5677430A | Antibodies directed against CD30 ligand | Chemistry; Metallurgy | 11 | Expired |
| US7211259B1 | 4-1BB polypeptides and DNA encoding 4-1BB polypeptides | Chemistry; Metallurgy | 8 | Expired |
| US6143869A | CD30 ligand oligomers and polypeptides | Chemistry; Metallurgy | 7 | Expired |
| US7875718B2 | Process for the synthesis of morphinane compounds and intermediates thereof | Chemistry; Metallurgy | 7 | Active |
| US7057022B2 | Antibodies which specifically bind to TNF-R | Physics | 6 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.